NextCure, Inc.NXTCNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank25
3Y CAGR-40.7%
5Y CAGR-34.7%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-40.7%/yr
Annual compound
5Y CAGR
-34.7%/yr
Recent deceleration
Percentile
P25
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
6 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $34.94M | -46.6% |
| 2024 | $65.47M | -42.8% |
| 2023 | $114.42M | -31.7% |
| 2022 | $167.53M | -28.2% |
| 2021 | $233.39M | -20.5% |
| 2020 | $293.72M | -8.6% |
| 2019 | $321.48M | +784.8% |
| 2018 | $-46.94M | -92.3% |
| 2017 | $-24.41M | - |